Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl Morrison

Showing results (61-70 of 113) with videos related to

Pageof 12
Sort By:
Plos Medicine|March 29, 2007
Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancerRomulo M Brena, Carl Morrison, Sandya Liyanarachchi, et al.
BMC Cancer|October 20, 2014
High focal adhesion kinase expression in breast carcinoma is associated with lymphovascular invasion and triple-negative phenotypeVita M Golubovskaya, Lourdes Ylagan, Austin Miller, et al.
Oncotarget|March 18, 2014
microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancersPierluigi Gasparini, Luciano Cascione, Matteo Fassan, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|February 27, 2007
Semi-automated imaging system to quantitate Her-2/neu membrane receptor immunoreactivity in human breast cancerAparna S Joshi, Girish M Sharangpani, Kyle Porter, et al.
The Prostate|January 8, 2019
Identification of targets for prostate cancer immunotherapyAntonios Papanicolau-Sengos, Yuanquan Yang, Sarabjot Pabla, et al.
Annals of Translational Medicine|February 11, 2021
Immune profiling and immunotherapeutic targets in pancreatic cancerFelicia L Lenzo, Shumei Kato, Sarabjot Pabla, et al.
Plos Medicine|December 30, 2006
A gene expression signature predicts survival of patients with stage I non-small cell lung cancerYan Lu, William Lemon, Peng-Yuan Liu, et al.
Gynecologic Oncology|April 3, 2007
Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinomaLouis A Dainty, John I Risinger, Carl Morrison, et al.
Future Oncology (London, England)|August 25, 2017
Challenges faced when identifying patients for combination immunotherapyMarc S Ernstoff, Shipra Gandhi, Manu Pandey, et al.
Genes, Chromosomes & Cancer|July 19, 2006
20q11.1 amplification in giant-cell tumor of bone: Array CGH, FISH, and association with outcomeLaura T Smith, Joel Mayerson, Norma J Nowak, et al.
Pageof 12

Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
Plos Medicine|March 29, 2007
Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancerRomulo M Brena, Carl Morrison, Sandya Liyanarachchi, et al.
BMC Cancer|October 20, 2014
High focal adhesion kinase expression in breast carcinoma is associated with lymphovascular invasion and triple-negative phenotypeVita M Golubovskaya, Lourdes Ylagan, Austin Miller, et al.
Oncotarget|March 18, 2014
microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancersPierluigi Gasparini, Luciano Cascione, Matteo Fassan, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|February 27, 2007
Semi-automated imaging system to quantitate Her-2/neu membrane receptor immunoreactivity in human breast cancerAparna S Joshi, Girish M Sharangpani, Kyle Porter, et al.
The Prostate|January 8, 2019
Identification of targets for prostate cancer immunotherapyAntonios Papanicolau-Sengos, Yuanquan Yang, Sarabjot Pabla, et al.
Annals of Translational Medicine|February 11, 2021
Immune profiling and immunotherapeutic targets in pancreatic cancerFelicia L Lenzo, Shumei Kato, Sarabjot Pabla, et al.
Plos Medicine|December 30, 2006
A gene expression signature predicts survival of patients with stage I non-small cell lung cancerYan Lu, William Lemon, Peng-Yuan Liu, et al.
Gynecologic Oncology|April 3, 2007
Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinomaLouis A Dainty, John I Risinger, Carl Morrison, et al.
Future Oncology (London, England)|August 25, 2017
Challenges faced when identifying patients for combination immunotherapyMarc S Ernstoff, Shipra Gandhi, Manu Pandey, et al.
Genes, Chromosomes & Cancer|July 19, 2006
20q11.1 amplification in giant-cell tumor of bone: Array CGH, FISH, and association with outcomeLaura T Smith, Joel Mayerson, Norma J Nowak, et al.
Pageof 12